Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Bruserud

Showing results (91-100 of 108) with videos related to

Pageof 11
Sort By:
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|October 30, 1994
[High-dose therapy with autologous stem cell support in malignant diseases]F Wisløff, L Brinch, O Bruserud, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|July 17, 1998
[Future requirements for hematologists]O Bruserud, S Berentsen, I M Dahl, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|October 30, 1994
[Treatment with high-dose cytostatic agents]F Wisløff, L Brinch, O Bruserud, et al.
European Journal of Haematology|January 1, 1998
Interleukin 4 responses in acute leukaemia patients with severe chemotherapy-induced leucopeniaO Bruserud, E Ulvestad, A Halstensen, et al.
Journal of Hematotherapy & Stem Cell Research|September 12, 2000
Autologous stem cell transplantation as post-remission therapy in adult acute myelogenous leukemia: does platelet contamination of peripheral blood mobilized stem cell grafts influence the risk of leukemia relapse?O Bruserud, B Foss, J F Abrahamsen, et al.
Cancer Immunology, Immunotherapy : CII|December 1, 1996
Human T lymphocyte activation in the presence of acute myelogenous leukaemia blasts: studies of allostimulated interferon-gamma secretionO Bruserud, L Mentzoni, B Foss, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|September 24, 2005
Serum levels of angioregulatory mediators in healthy individuals depend on age and physical activity: studies of angiogenin, basic fibroblast growth factor, leptin and endostatinO Bruserud, F Grovan, R Lindås, et al.
Bone Marrow Transplantation|August 1, 1991
Cytotoxic and proliferative functions of T lymphocyte clones derived very shortly after allogeneic bone marrow transplantationW Hamann, O Bruserud, S Patel, et al.
European Journal of Haematology|August 1, 1993
IFN-gamma and TNF-alpha secretion by CD4+ and CD8+ TCR alpha beta + T-cell clones derived early after allogeneic bone marrow transplantationO Bruserud, W Hamann, S Patel, et al.
European Journal of Haematology|July 1, 1996
Interleukin 1 receptor antagonist (IL1RA) in acute leukaemia: IL1RA is both secreted spontaneously by myelogenous leukaemia blasts and is a part of the acute phase reaction in patients with chemotherapy-induced leucopeniaO Bruserud, I Aasen, P E Akselsen, et al.
Pageof 11

Showing results (91-100 of 108) with videos related to

Sort By:
Pageof 11
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|October 30, 1994
[High-dose therapy with autologous stem cell support in malignant diseases]F Wisløff, L Brinch, O Bruserud, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|July 17, 1998
[Future requirements for hematologists]O Bruserud, S Berentsen, I M Dahl, et al.
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|October 30, 1994
[Treatment with high-dose cytostatic agents]F Wisløff, L Brinch, O Bruserud, et al.
European Journal of Haematology|January 1, 1998
Interleukin 4 responses in acute leukaemia patients with severe chemotherapy-induced leucopeniaO Bruserud, E Ulvestad, A Halstensen, et al.
Journal of Hematotherapy & Stem Cell Research|September 12, 2000
Autologous stem cell transplantation as post-remission therapy in adult acute myelogenous leukemia: does platelet contamination of peripheral blood mobilized stem cell grafts influence the risk of leukemia relapse?O Bruserud, B Foss, J F Abrahamsen, et al.
Cancer Immunology, Immunotherapy : CII|December 1, 1996
Human T lymphocyte activation in the presence of acute myelogenous leukaemia blasts: studies of allostimulated interferon-gamma secretionO Bruserud, L Mentzoni, B Foss, et al.
Scandinavian Journal of Clinical and Laboratory Investigation|September 24, 2005
Serum levels of angioregulatory mediators in healthy individuals depend on age and physical activity: studies of angiogenin, basic fibroblast growth factor, leptin and endostatinO Bruserud, F Grovan, R Lindås, et al.
Bone Marrow Transplantation|August 1, 1991
Cytotoxic and proliferative functions of T lymphocyte clones derived very shortly after allogeneic bone marrow transplantationW Hamann, O Bruserud, S Patel, et al.
European Journal of Haematology|August 1, 1993
IFN-gamma and TNF-alpha secretion by CD4+ and CD8+ TCR alpha beta + T-cell clones derived early after allogeneic bone marrow transplantationO Bruserud, W Hamann, S Patel, et al.
European Journal of Haematology|July 1, 1996
Interleukin 1 receptor antagonist (IL1RA) in acute leukaemia: IL1RA is both secreted spontaneously by myelogenous leukaemia blasts and is a part of the acute phase reaction in patients with chemotherapy-induced leucopeniaO Bruserud, I Aasen, P E Akselsen, et al.
Pageof 11